Your session is about to expire
← Back to Search
Video-based Intervention for Suicide Prevention
N/A
Waitlist Available
Led By Brandon Gaudiano, PhD
Research Sponsored by Butler Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
Study Summary
This trial will test a new suicide prevention intervention called LifePlans. It will be given to patients who have been admitted to a psychiatric hospital for suicidal thoughts and behaviors. The trial will assess the feasibility and acceptability of the intervention.
Who is the study for?
This trial is for adults over 18 who are currently hospitalized for suicidal thoughts and behaviors, can speak and read English, and have a way to watch videos. People with cognitive impairments or current psychotic symptoms cannot participate.Check my eligibility
What is being tested?
The study is testing 'LifePlans,' a new video-based suicide prevention tool, against the usual treatment methods. Participants will be randomly assigned to one of these two groups and followed up with after 1 month and again at 6 months post-hospital discharge.See study design
What are the potential side effects?
Since 'LifePlans' is a non-medical intervention focusing on educational videos, there may not be direct side effects like those seen with medications; however, emotional discomfort due to sensitive content could occur.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Client Satisfaction Questionnaire (CSQ)
Secondary outcome measures
Columbia Suicide Severity Rating Scale (C-SSRS)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: LifePlansExperimental Treatment1 Intervention
LifePlans is a video series using real patients telling their stories of overcoming suicidal thoughts and behaviors to help others who are struggling with these issues.
Group II: Treatment as UsualActive Control1 Intervention
Individuals will receive unrestricted routine care only.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LifePlans
2022
N/A
~50
Find a Location
Who is running the clinical trial?
Butler HospitalLead Sponsor
129 Previous Clinical Trials
16,378 Total Patients Enrolled
Brandon Gaudiano, PhDPrincipal InvestigatorButler Hospital
7 Previous Clinical Trials
473 Total Patients Enrolled
Lisa Uebelacker, PhDPrincipal InvestigatorButler Hospital
9 Previous Clinical Trials
1,128 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have trouble thinking or remembering things.You are currently experiencing symptoms of psychosis.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment as Usual
- Group 2: LifePlans
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies remaining to participate in this experiment?
"Affirmative. The information available on clinicaltrials.gov confirms that as of February 28th 2022, this medical study is recruiting participants at one site with a target sample size of 40 individuals. This trial was initially posted on January 1st 2022."
Answered by AI
How wide is the scope of participants for this experiment?
"Right, current information from clinicaltrials.gov demonstrates that recruitment for this trial is ongoing. It was initially announced on the first of January 2022 and recently revised on February 28th 2022; it needs to find 40 suitable candidates across a single site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger